Filling Machine Liquid

Filling Machine Liquid

Rheology-Driven Pump Selection for Pharmaceutical Liquids

The pump technology for a pharmaceutical liquid filler should be selected from the product's rheology and gas-handling behavior first, not from the supplier's catalog, because the dominant reject modes in liquid filling — foam, shear damage, and dose error — are all consequences of mismatching viscosity or surface tension to the pump, and they appear only after validation when the line is already paid for. Where the liquid is low-viscosity, low-surface-tension, and shear-sensitive, time-pressure or peristaltic metering beats piston pumps; where it is viscous or particulate, piston or rotary lobe wins. The decision is a measurement, not a preference.

This guidance is built from commissioning data on ophthalmic, otic, suspension, and syrup lines across South Korea, Turkey, Germany, and the UAE. It quantifies the foaming and shear differences between the four common metering architectures, shows the accuracy and shear-rate numbers we recorded at 2.5 mL, maps the regulatory expectations in the EU, US, Southeast Asia, and Middle East, and lists the selection errors that repeatedly fail factory acceptance tests.

Filling Machine Liquid

Technology Comparison Matrix

Four metering principles cover nearly all pharmaceutical liquid filling: peristaltic (tube occluded by rollers), piston (positive-displacement cylinder), time-pressure (a fixed head pressure metered by open-time), and rotary lobe (two intermeshing rotors). Their behavior diverges sharply on viscosity ceiling, shear rate, foaming tendency, and achievable accuracy.

Metering principle Viscosity range (cP) Shear rate (1/s) Foaming risk Accuracy (±)
Peristaltic 1–5,000 Low (tube gentle) Medium (air entrainment at rollers) 0.5–2.0 %
Piston 50–20,000 Medium Low (no free fall) 0.3–1.0 %
Time-pressure 1–500 Very low (laminar) Lowest (no moving contact) 0.5–1.5 %
Rotary lobe 100–100,000 High (rotor gap) Medium 0.5–1.5 %

Peristaltic and time-pressure are the two choices for shear-sensitive biologics and clear ophthalmic solutions because neither exposes the product to high shear or a metal contact gap that can shed particles. Piston and lobe are needed when viscosity climbs above a few thousand cP or when the liquid carries suspended solids that would pack a peristaltic tube. Time-pressure is the only architecture with effectively zero moving product contact, which is why it dominates small-volume aseptic eye drops.

Measured Performance Benchmarks

Benchmarks were taken on a 2.5 mL target using a calibrated gravimetric check (0.1 mg resolution), with foaming indexed as the volume of entrained gas measured in a sight glass after 50 fills, and shear rate estimated from pump geometry and flow velocity.

Metric Peristaltic Time-pressure Piston
Fill accuracy at 2.5 mL (±) 1.6 % 1.0 % 0.8 %
Foaming index (mL gas / 100 mL) 4.2 0.3 1.1
Peak shear rate (1/s) 120 35 240
CIP recovery time (min) 8 (tube strip) 18 (loop rinse) 25 (valve strip)

The foaming index is the number that decides ophthalmic lines. A peristaltic pump at 4.2 mL gas per 100 mL entrains enough air to leave micro-bubbles in a 2.5 mL dropper bottle, which reads as a fill shortfall on the checkweigher and as a visible defect on inspection. Time-pressure at 0.3 is effectively foam-free because the liquid is pushed by a steady gas or liquid head with no roller occlusion. The shear-rate column matters for protein or peptide solutions: anything above ~200 1/s can denature shear-sensitive molecules, so piston and lobe are ruled out for those products regardless of their better accuracy.

Speed matters too. At 2.5 mL, time-pressure held 80 bottles/min per head with ±1.0 %; peristaltic reached 110/min but at the cost of the 1.6 % accuracy and the foam problem. The selection is therefore a three-way trade among accuracy, foam, and shear, resolved by the product's tolerance window.

Regional Compliance Map

EU GMP (EudraLex Vol 4, Annex 1)

Aseptic liquid filling runs under Grade A in Grade B background; the 2022 Annex 1 revision expects single-use or fully drainable product-contact parts and places heavy weight on contamination control strategy (CCS) documentation. For device-linked formats (droppers, prefilled syringes) ISO 13485 applies on the device side. USP <771> Ophthalmic Products sets fill-volume and leaker expectations that EU auditors reference informally even though it is a US compendial chapter.

US FDA (21 CFR 820 and 211)

Liquid drugs follow 21 CFR 211 for CGMP; if the container is a medical device (dropper tip, metered pump) 21 CFR 820 (QSR) governs design controls. USP <771> is enforceable for ophthalmic preparations and specifies that the average fill may not be less than label claim and individual units must meet tight minima. FDA inspectors probe CIP/SIP validation and data integrity on the fill records harder than most other regions.

Southeast Asia

Indonesia (BPOM), Thailand (FDA), and Malaysia (NPRA) accept PIC/S-aligned GMP and ISO 13485 for device-format liquids, but tropical plants face real CIP-rinse-water microbial limits that European templates ignore. We specify final rinse at < 10 CFU/mL and a documented drainability check. India (CDSCO) requires viscosity and foaming characterization in the dossier and expects a design qualification (DQ) record before installation qualification begins.

Middle East

In the Gulf, SFDA and UAE MOHAP conduct GMP audits aligned to PIC/S and insist on batch-traceable filling data with Arabic labeling before product release. Summer utility water in this region runs hot enough to stress CIP loop seals, so we build SIP-capable circuits even on non-sterile liquid lines to keep microbiological control through the peak season. Where the dropper or metered pump is imported from outside the GCC, SFDA requires ISO 13485 documentation on the device component.

What Breaks in the Field

1. Pump chosen from viscosity alone, ignoring foam

Root cause: a peristaltic pump is specified because the viscosity fits, but the low-surface-tension solution foams at the rollers and the dropper bottles reject. Fix: qualify the foaming index during DQ; for clear aqueous solutions below 500 cP, default to time-pressure with a sub-surface nozzle.

2. Shear foaming and protein damage

Root cause: a piston pump is used on a peptide solution; shear at 240 1/s denatures the molecule and generates foam. Fix: cap product shear below ~100 1/s using time-pressure or peristaltic, and document the shear budget in the process validation.

3. No validated CIP / SIP loop

Root cause: the product-contact path is assembled without drainable slopes, so rinse water pools and microbiological limits fail. Fix: design all contact parts to full drainability (> 1° slope), define a CIP sequence with conductivity endpoints, and for sterile lines add SIP at 121 °C for 30 min with a documented cool-down.

4. Missing sub-surface (bottom-up) nozzle

Root cause: a top-fill nozzle drops liquid onto a pool, entraining air and splashing the container walls. Fix: use a diving or sub-surface nozzle that fills from the bottom up; on the Seoul line this single change removed all visible foam at 2.5 mL.

5. No design qualification (DQ) before install

Root cause: the buyer accepts the machine on price and only discovers the pump is wrong during OQ, after utilities are committed. Fix: require a DQ document that maps each product's rheology window to the selected pump and nozzle, signed before FAT.

6. Head-pressure drift in time-pressure systems

Root cause: the supply tank level drops during a run, changing the driving pressure and the dose. Fix: use a constant-level tank or a pressure regulator with a closed-loop controller, and alarm on any ±2 % pressure deviation.

7. Tube fatigue in peristaltic fillers

Root cause: the silicone or PharMed tube is run past its cycle life, swelling and changing the dispensed volume. Fix: track roller passes per tube (typically 200–400 h depending on fluid) and replace on a preventive schedule verified during PQ.

Commissioning Case Files

Case 1 — Seoul, South Korea: latanoprost eye drops, 2.5 mL LDPE dropper

Product: preservative-free latanoprost ophthalmic solution, 2.5 mL into an LDPE dropper bottle, Grade A aseptic line. As-found: a peristaltic filler was installed for its low shear, but at 2.5 mL the roller occlusion entrained air and the foaming index measured 4.2 mL gas per 100 mL. Checkweigher rejects ran at 3.1 % and visible micro-bubbles failed visual inspection. Accuracy sat at ±1.6 %.

Remediation: replaced peristaltic with a time-pressure head feeding a diving sub-surface nozzle that entered the bottle before flow started and withdrew as the level rose. Foaming index fell to 0.3, rejects dropped below 0.2 %, and accuracy tightened to ±1.0 % at 80 bottles/min per head. The change also removed the peristaltic tube as a consumable and its extractable-risk profile, which simplified the extractables leachables dossier for the Korean MFDS submission.

Case 2 — Turkey: otic suspension, viscosity shift across batches

Product: antibiotic otic suspension, target 5 mL, supplied as a concentrate diluted per batch. As-found: the piston filler was qualified at 1,800 cP but a reformulated batch arrived at 3,400 cP; the piston could not complete stroke in the timed window and dose fell to −6 % on the low side. The supplier had not captured viscosity as an incoming lot parameter.

Remediation: added an incoming rheology check (brookfield spindle at 20 rpm, 25 °C) as a lot-release gate, and re-qualified the piston stroke timing against the measured viscosity band of 1,500–3,500 cP. Where the batch exceeded 3,200 cP, the controller automatically extended stroke time by 0.4 s. Accuracy returned to ±0.9 % across the band and no further underfills were recorded through the following quarter.

Buyer FAQ

What viscosity range can each pump handle?

Peristaltic covers roughly 1–5,000 cP, time-pressure 1–500 cP, piston 50–20,000 cP, and rotary lobe 100–100,000 cP. The practical ceiling also depends on shear sensitivity: a shear-sensitive product should stay below ~100 1/s, which rules piston and lobe out even when the viscosity fits.

How do I stop foaming in small-volume filling?

Foam comes from air entrainment, so eliminate the air path: use time-pressure metering with a sub-surface diving nozzle, keep the liquid laminar (shear < 50 1/s), and avoid free-fall into the container. On clear aqueous drops this reliably brings the foaming index under 0.5.

Which technology for small-volume aseptic liquids?

For 0.5–10 mL ophthalmic and injectable formats, time-pressure with a diving nozzle is the default because it has no moving product contact, the lowest shear, and near-zero foam. Peristaltic is acceptable for shear-sensitive non-aseptic products if the tube extractables are qualified.

Do I need CIP or full SIP?

Non-sterile lines need validated CIP with a conductivity endpoint and documented drainability. Sterile aseptic lines need SIP at 121 °C for 30 min on all product-contact parts, plus a controlled cool-down. Gulf plants should specify SIP-capable loops even for non-sterile product because utility water temperatures make microbial control harder.

Why is design qualification (DQ) non-negotiable?

DQ maps the product rheology window to the pump and nozzle before money is committed to installation. Skipping it is how a buyer discovers the pump is wrong at OQ, after utilities and cleanroom time are spent. Regulators in India, the EU, and the US expect the DQ record in the validation package.

How accurate is time-pressure versus piston?

At 2.5 mL we measured ±1.0 % for time-pressure and ±0.8 % for piston. The 0.2-point gap rarely matters for ophthalmic minima, while the foam and shear advantages of time-pressure decide the line. For viscous non-shear-sensitive liquids, piston's accuracy and lack of foam make it the better choice.

Can one machine run both thin and thick products?

Only with change parts and re-qualification. Peristaltic and piston share a cabinet but need different tubes or cylinder sizes; time-pressure needs a different nozzle and pressure setpoint. Treat each viscosity regime as a separate validated state and document the changeover.


Written by Helen Xu | Chief Industrial Application Engineer

Helen Xu is a Chief Industrial Application Engineer with 9 years of specialized experience in packaging machinery and liquid filling machine design, equipment model selection, and full production line process optimization. He focuses on delivering customized packaging & filling solutions for pharmaceutical, food, and chemical manufacturing industries, with mature practical expertise in GMP compliance, ISO 9001 quality management standards, and turnkey large-scale filling & packaging production line integration.

E-mail Us

  • Afghanistan
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antarctica
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos (Keeling) Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'Ivoire
  • Croatia
  • Cuba
  • Cyprus
  • Czech Republic
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands (Malvinas)
  • Faroe Islands
  • Fiji
  • Finland
  • France, Metropolitan
  • French Guiana
  • French Polynesia
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hong Kong,China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran (Islamic Republic of)
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • North Korea
  • South Korea
  • Kuwait
  • Kyrgyzstan
  • Lao People's Democratic Republic
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libyan Arab Jamahiriya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russian Federation
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Saudi Arabia
  • Senegal
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovak Republic
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • Spain
  • Sri Lanka
  • St. Helena
  • Sudan
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • Taiwan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican City State (Holy See)
  • Venezuela
  • Viet Nam
  • Virgin Islands (U.S.)
  • Wallis and Futuna Islands
  • Western Sahara
  • Yemen
  • Zambia
  • Zimbabwe
  • Montenegro
  • Serbia
  • Palestine
  • South Sudan
  • Jersey

Chat With Us